ISSN 2415-3060 (print), ISSN 2522-4972 (online)
  • 14 of 58
Up
JMBS 2020, 5(6): 102–109
https://doi.org/10.26693/jmbs05.06.102
Clinical Medicine

Mathematical Analysis of Evaluating the Homocystein Level in Serum as a Predictor of Meningitis Development in Newborn with Hypoxic-Ischemic Injury of the Central Nervous System

Volotko L. O.
Abstract

The main reason for the development of neonatal hypoxic-ischemic encephalopathy is inadequate oxygen supply to brain tissue, due to a combination of hypoxemia and ischemia. Hypoxia leads to disruption of oxidative processes and the development of acidosis, decreased energy balance of the cell, an excess of excitatory neurotransmitters, impaired metabolism of glia and neurons. Excess homocysteine can also induce a cascade of events in hippocampal neurons, producing in response to acute bacterial meningitis and accumulating in the central nervous system, reaching neurotoxic levels. Understanding the pathological mechanisms of neonatal ischemic Brain injury will help optimize treatment and reduce the degree of hypoxic-ischemic damage. The purpose of the study was to assess the level of homocysteine in the blood serum as a predictor of the development of meningitis in newborns with hypoxic-ischemic lesions of the central nervous system using mathematical analysis. Material and methods. The following research methods were used in the course of work: clinical-anamnestic (subjective and objective examination data), laboratory (biochemical, immunological method, enzyme-linked immunosorbent assay method), instrumental (neurosonography), methods of mathematical statistics. Statistical processing of all obtained results performed on a personal computer using the license software package Statistics 13.0 (StatSoftInc, serial number JPZ8041382130ARCN10-J) and MS Excel. We used the following methods of statistical analysis in the study: descriptive statistics, parametric and nonparametric methods of comparison of mean groups, correlation analysis, multiple linear and logistic regression analysis, utility statistics: odds ratio, relative risk, ROC analysis. Results and discussion. The relationship between homocysteine and hemoglobin and gestational age was found to be direct and reversed with bilirubin. The use of linear regression analysis allowed predicting the value of homocysteine by known values of one or more predictor variables. A ROC analysis was performed to assess the diagnostic significance of homocysteine levels as an indicator of oxidative stress and to express it in some integral indicators. Conclusion. The analysis showed that high levels of homocysteine in newborns can be considered as a statistically significant indicator of oxidative stress and a predictor of meningitis in premature infants. The probability of developing meningitis in premature infants with high homocysteine levels is 1.15 times higher than in full-term infants with central nervous system lesions (p> 0.05) and 8 times higher (p <0.05) than in full-term relatively healthy infants

Keywords: hypoxic-ischemic encephalopathy, meningitis, homocysteine, ROC analysis, linear regression analysis

Full text: PDF (Ukr) 308K

References
  1. Vasileva MA, Potapova VE. Differentsialnaya diagnostika porazheniy TsNS u novorozhdennykh: znachenie likvorologicheskogo issledovaniya [Differential diagnosis of CNS lesions in newborns: the value of liquorological examination]. Dostizheniya fundamentalnoy, klinicheskoy meditsiny i farmatsii: materialy 72-y nauch ses sotr un-ta, 25-26 Jan 2017 g. Vitebsk: VGMU, 2017, 2017: 246-248. [Russian]
  2. Izyumets OI, Layko LI, Gomon RA, Dobizha MV, Nezhivenko TP, Shamray IE. Gipoksicheski-ishemicheskie povrezhdeniya tsentralnoy nervnoy sistemy u novorozhdennykh [Shamrai IE. Hypoxic-ischemic damage to the central nervous system in newborns]. Sovremennaya pediatriya. 2013; 7: 136-139. [Russian]
  3. Namazova-Baranova LS, Deev IA, Kobyakova OS, Kulikova KV, Kulikov ES, Zhelev VA. Osobennosti somaticheskoy patologii u detey s nizkoy, ochen nizkoy i ekstremalno nizkoy massoy tela pri rozhdenii v razlichnye vozrastnye periody zhizni [Features of somatic pathology in children with low, very low and extremely low birth weight at different age periods of life]. Byulleten sibirskoy meditsiny. 2016; 15(4): 140-149. [Russian] https://doi.org/10.20538/1682-0363-2016-4-140-149
  4. Blinov DV. Sovremennye podkhody k patogenezu i prognozirovaniyu iskhodov gipoksicheski-ishemicheskogo porazheniya TsNS v perinatalnom periode [Modern approaches to the pathogenesis and prediction of the outcomes of hypoxic-ischemic CNS damage in the perinatal period]. Akusherstvo, ginekologiya i reproduktsiya. 2012; 6(3): 34-38. [Russian]
  5. Makarenko MV, Govseev DA, Skirda II, Ryzhova OA, Sysa ON. Uroven gomotsisteina i sostoyanie gemostaza kak sopryazhennye markery blagopoluchiya fetoplatsentarnogo obmena [The level of homocysteine and the state of hemostasis as conjugate markers of the well-being of fetoplacental metabolism]. Zdorove zhenshchiny. 2015; 6(102): 94-96. [Russian]
  6. Afonaseva TM. Endotelialnaya disfunktsiya. Vozmozhnosti ranney diagnostiki [Endothelial dysfunction. Early diagnosis possibilities]. The Journal of scientific articles “health and education Millenium”. 2016; 18(11): 101-104. [Russian]
  7. Perła-Kaján J, Twardowski T, Jakubowsk H. Mechanisms of homocysteine toxicity in humans. Amino Acids. 2007; 32(4): 561-572. https://doi.org/10.1007/s00726-006-0432-9
  8. Morettia R, Dal Benb M, Gazzinb S and Tiribellib C. Homocysteine in Neurology: From Endothelium to Neurodegeneration. Curr Nutr Food Science. 2017; 13: 163-175. https://doi.org/10.2174/1573401313666170213155338
  9. Coimbra RS, Calegare BFrA, Talitah MSC, Vânia D’A. A putative role for homocysteine in the pathophysiology of acute bacterial meningitis in children. BMC Clin Pathol. 2014; 14: 43. https://doi.org/10.1186/1472-6890-14-43
  10. Patent 137635 Ukraine, МПК (2006): G01N 33/00, G01N 33/50 (2006.01). Sposib rannoyi diagnostyky gniynogo meningitu u novonarodzhenykh, shcho narodylys peredchasno [A method for early diagnosis of purulent meningitis in premature infants] / Martynyuk VYu, Lezhenko GO, Volotko LO. (UA); zayavnik i vlasnik patentu Martynyuk Volodymyr Yuriyovych (UA). № u201904976; zayavl 10.05.2019; opubl 25.10.2019. Byul № 20. [Russian]